Shanghai, China

Changling Gu


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Changling Gu: Innovator in Antibody Development

Introduction

Changling Gu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions.

Latest Patents

Changling Gu holds a patent for an Anti-HER2/PD1 bispecific antibody. This invention includes a preparation method and antitumor application. The bispecific antibody is designed to target both the HER2 antigen on tumor cells and the PD-1 molecule on T lymphocytes. Experimental results indicate that this antibody can inhibit the proliferation of HER2-positive tumor cells while blocking the PD-1/PD-L1 interaction, thereby enhancing T cell activity and promoting antitumor effects.

Career Highlights

Changling Gu is associated with Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His work focuses on advancing cancer therapies through innovative antibody designs. His research has the potential to significantly impact cancer treatment protocols.

Collaborations

Changling Gu collaborates with notable colleagues, including Zhenping Zhu and Haomin Huang. Their combined expertise contributes to the advancement of therapeutic innovations in the pharmaceutical industry.

Conclusion

Changling Gu's work in developing bispecific antibodies represents a significant advancement in cancer therapy. His innovative approach has the potential to improve treatment outcomes for patients with HER2-positive tumors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…